Molecular Profile
NAD+ Structure
Essential dinucleotide coenzyme
CoenzymeEndogenous
CAS Number53-84-9
Molecular FormulaC21H27N7O14P2
Molecular Weight663.43 g/mol
TypeDinucleotide coenzyme
ComponentsNicotinamide + Adenine + Ribose + Phosphate
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Cellular Peptide
NAD+
Nicotinamide Adenine DinucleotideCoenzyme IBeta-NAD
A critical dinucleotide coenzyme that activates sirtuins and supports mitochondrial function, studied for cellular energy metabolism in research models.
Dosage
Quantity
1
$69.99
Dosage
Quantity
1
$69.99
Thu, Apr 30 - Wed, May 6
Overnight shipping available
We accept
NAD+$69.99
Free shippingon orders over $150
Damageprotection
Secure checkout256-bit SSL
Compound Information
Chemical and structural properties
Biological Targets
Enzyme Interactions
Essential cofactor for multiple enzyme families
SirtuinsSIRT1-7 deacetylases
PARPsDNA repair enzymes
CD38/CD157NAD+ glycohydrolases
Oxidoreductases500+ enzymes
Physical Properties
Handling & Storage
Stability and storage requirements
AppearanceWhite to off-white powder
SolubilityFreely soluble in water
Storage (powder)-20°C, protected from light
Solution stabilityUse promptly, refrigerate
Sources & References
Peer-reviewed research
Frontiers in Endocrinology
Association of Human Whole Blood NAD+ Contents With Aging
2022•DOI: 10.3389/fendo.2022.829658•PMID: 35370948
Yang F, et al.
View Source
Trends in Cell BiologyNAD+ and Sirtuins in Aging and Disease
2014•PMID: 24786309
Imai S, Guarente L
View Source
AntioxidantsA Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+
2019•PMID: 31508207
Grant R, et al.
View Source
CirculationNAD+ Metabolism in Cardiac Health, Aging, and Disease
2021•PMID: 34843394
Abdellatif M, et al.
View Source
Nature MetabolismNAD+ Homeostasis in Health and Disease
2020•PMID: 32694684
Katsyuba E, et al.
View Source
Circulation ResearchSirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases
2018•PMID: 30355082
Kane AE, Sinclair DA
View Source
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
